A Phase 1 Study Of A Novel Spectrum Selective Inhibitor (Sski), Xl880, Administered Orally In Patients With Advanced Solid Malignancies.P Lorusso,L Appleman, E Heath,L Malburg,Ax Zhu, M Carey, Gi Shapiro,Jp EderCLINICAL CANCER RESEARCH(2005)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要